Romain Loyon

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 5

Top Topics

Editorial Comment

Dendritic Cells

Top Venues

Cancer gene therapy

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Valentine De Castro, Jeanne Galaine, Romain Loyon, Yann Godet
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy. Cancer gene therapy (2024)
Valentine De Castro, Jeanne Galaine, Romain Loyon, Yann Godet
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy. Cancer gene therapy 31 (8) (2024)
Myriam Ben Khelil, Yann Godet, Syrine Abdeljaoued, Christophe Borg, Olivier Adotévi, Romain Loyon
Harnessing Antitumor CD4 + T Cells for Cancer Immunotherapy. Cancers 14 (1) (2022)
Romain Loyon, Emilie Picard, Olivier Mauvais, Lise Queiroz, Virginie Mougey, Jean-René Pallandre, Jeanne Galaine, Patricia Mercier-Letondal, Guillaume Kellerman, Nathalie Chaput, John Wijdenes, Olivier Adotévi, Christophe Ferrand, Pedro Romero, Yann Godet, Christophe Borg
IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. Journal of immunology (Baltimore, Md. : 1950) 197 (1) (2016)
Jeanne Galaine, Guillaume Kellermann, Yves Guillaume, Romain Boidot, Emilie Picard, Romain Loyon, Lise Queiroz, Laura Boullerot, Laurent Beziaud, Marine Jary, Laura Mansi, Claire André, Lydie Lethier, Evelyne Ségal-Bendirdjian, Christophe Borg, Yann Godet, Olivier Adotévi
Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells. Journal of immunology (Baltimore, Md. : 1950) 197 (5) (2016)